iHuman (IH) Cash & Equivalents (2020 - 2024)
iHuman (IH) has disclosed Cash & Equivalents for 5 consecutive years, with $156.4 million as the latest value for Q4 2024.
- Quarterly Cash & Equivalents fell 7.24% to $156.4 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $156.4 million through Dec 2024, down 7.24% year-over-year, with the annual reading at $153.9 million for FY2024, 9.98% down from the prior year.
- Cash & Equivalents for Q4 2024 was $156.4 million at iHuman, down from $168.6 million in the prior quarter.
- The five-year high for Cash & Equivalents was $168.6 million in Q4 2023, with the low at $130.0 million in Q4 2020.
- Average Cash & Equivalents over 5 years is $147.3 million, with a median of $147.6 million recorded in 2022.
- The sharpest move saw Cash & Equivalents increased 14.19% in 2023, then decreased 7.24% in 2024.
- Over 5 years, Cash & Equivalents stood at $130.0 million in 2020, then increased by 2.9% to $133.8 million in 2021, then increased by 10.35% to $147.6 million in 2022, then rose by 14.19% to $168.6 million in 2023, then dropped by 7.24% to $156.4 million in 2024.
- According to Business Quant data, Cash & Equivalents over the past three periods came in at $156.4 million, $168.6 million, and $147.6 million for Q4 2024, Q4 2023, and Q4 2022 respectively.